Diagnostic and prognostic value of in vivo proton MR spectroscopy for Zellweger syndrome spectrum patients.

about

Diagnostic and prognostic value of in vivo proton MR spectroscopy for Zellweger syndrome spectrum patients.

Item

http://www.wikidata.org/entity/Q48129038

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Diagnostic and prognostic valu ...... er syndrome spectrum patients.

@en

Diagnostic and prognostic valu ...... er syndrome spectrum patients.

@nl

type

Item

label

Diagnostic and prognostic valu ...... er syndrome spectrum patients.

@en

Diagnostic and prognostic valu ...... er syndrome spectrum patients.

@nl

prefLabel

Diagnostic and prognostic valu ...... er syndrome spectrum patients.

@en

Diagnostic and prognostic valu ...... er syndrome spectrum patients.

@nl

P1476

Diagnostic and prognostic valu ...... ger syndrome spectrum patients

@en

P2093

A Ohlenbusch

http://www.w3.org/2001/XMLSchema#string

C Krause

http://www.w3.org/2001/XMLSchema#string

J Gärtner

http://www.w3.org/2001/XMLSchema#string

K Brockmann

http://www.w3.org/2001/XMLSchema#string

P Dechent

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic and molecular basis of peroxisomal disorders: a review

Peroxisome biogenesis disorders

Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients.

Serial proton MR spectroscopy and diffusion tensor imaging in infantile Balo's concentric sclerosis.

Regional variation in brain lactate in Leigh syndrome by localized 1H magnetic resonance spectroscopy.

Characterization of two common 5' polymorphisms in PEX1 and correlation to survival in PEX1 peroxisome biogenesis disorder patients.

Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy.

Rational diagnostic strategy for Zellweger syndrome spectrum patients

Magnetic resonance spectroscopy in Niemann-Pick disease type C: correlation with diagnosis and clinical response to cholestyramine and lovastatin.

Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder.

P2888

s10545-016-9965-6

P304

869-876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10545-016-9965-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

H Rosewich

P577

2016-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27488561

http://www.w3.org/2001/XMLSchema#string